Evidence-based recommendations on treating locoregional and distant metastases of carcinomas of the breast;Evidenzbasierte empfehlungen zur behandlung von lokoregionär und fernmetastasierten mammakarzinomen: Der konsens der AGO-organkommission "mamma"

Zentralblatt fur Gynakologie

Volumn 124, Issue 5, 2002, Pages 284-292

  Von Minckwitz, G ^a   Costa, S D ^a   Brunnert, K ^a   Dall, P ^a   Nitz, U ^a   Diel, I ^a   Fersis, N ^a   Friedrich, M ^a   Friedrichs, K ^a   Thomssen, Ch ^a   Gerber, B ^a   Gohring U J ^a   Harbeck, N ^a   Hanf, V ^a   Schaller, G ^a   Scharl, A ^a   Schmutzler, R ^a   Simon, W E ^a   Untch, M ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; ANTHRACENE; ANTHRACYCLINE; BISPHOSPHONIC ACID DERIVATIVE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ERYTHROPOIETIN; FLUOROURACIL; GEMCITABINE; GESTAGEN; GONADORELIN AGONIST; GRANULOCYTE COLONY STIMULATING FACTOR; MITOXANTRONE; NAVELBINE; PACLITAXEL; STEROID; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

ARTICLE; BREAST CARCINOMA; BREAST METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER IMMUNOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; EVIDENCE BASED MEDICINE; HUMAN; MASTECTOMY; OVARIECTOMY; STEROID THERAPY; TREATMENT INDICATION;

BREAST NEOPLASMS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; NEOPLASM METASTASIS;

EID: 16744364520     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-34094     Document Type: Article

References (54)

1. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology
2. Preventive Health Care, 1999 update: 3. Follow-up after breast cancer
3. Tumor marker utility grading system: A framework to evaluate clinical utility of tumor markers
4. Recurrences, the surgical and radiological side effects and new developments in the breast-preserving treatment of breast carcinoma
5. Local-regional recurrence after mastectomy or breast conserving therapy
6. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials
7. The role of computed tomography in the evaluation of post-mastectomy locally recurrent breast cancer
8. Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer
9. Is breast conservation after local recurrence feasible?
10. First isolated locoregional recurrence following mastectomy for breast cancer: Results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation
11. Long-term survival after chest-wall reconstruction with musculocutaneous flaps
12. The use of radiotherapy for treatment of isolated locoregional recurrence of breast carcinoma after mastectomy
13. Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study
14. Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: A meta-analysis of four randomized trials
15. Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy
16. Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer
17. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials
18. Intraarterial infusion chemotherapy and radiotherapy with or without surgery for patients with locally advanced or recurrent breast cancer
19. Systemische therapie metastasierter mammakarzinome
20. Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: Results of a North American multicenter randomized trial
21. Hormonelle folgetherapien nach goserelin (zoladex®) beim metastasierten mammakarzinom prämenopausaler patientinnen
22. Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: An intergroup study
23. Comparison of chemotherapy with chemohormonal therapy as first-line therapy for metastatic, hormone-sensitive breast cancer: An Eastern Cooperative Oncology Group study
24. Cytotoxic and hormonal treatment for metastatic breast cancer: A systematic review of published randomized trials involving 31510 women
25. Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer
26. Balance of time to progression, quality of life, and overall survival: More gain from treatment in single agent treatment with mitoxantrone (N) than with the combination of fluorouracil, epirubicin, cyclophosphamide (Fec). Results of a multicenter randomized trial
27. Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older
28. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer
29. Current use of HER2 tests
30. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
31. Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer
32. Cardiac dysfunction in the trastuzumab clinical trials experience
33. Treatment of metastatic bone disease in breast cancer: Bisphosphonates
34. Metasasectomy as a cytoreductive strategy for treatment of isolated pulmonary and hepatic metastases from breast cancer
35. Review article: Liver metastases: Interventional therapeutic techniques and results, state of the art
36. Long-term survival with metastatic cancer to the brain
37. Identification of prognostic factors in patients with brain metastases: A review of 1 292 patients
38. Solitary brain metastases treated with the Leksell gamma knife: Prognstic factor for patients
39. Surgical treatment of 70 patients with brain metastases from breast carcinoma
40. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age
41. Topotecan chemotherapy in patients with breast cancer and brain metastasis: Results of a pilot study
42. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions
43. Intrapericardial treatment of neoplastic pericardial effusions
44. Rationale therapie mit den hämatopoetischen wachstumsfaktoren G-CSF und GM-CSF
45. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants
46. Chemotherapy-induced anemia in adults: Incidence and treatment
47. The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: A randomized controlled clinical trial
48. Follow-up after treatment for breast cancer
49. Nachsorge
50. Recommended breast cancer surveillance guidelines. Adopted on February 20, 1997 by the American Society for Clinical Oncology (ASCO)
51. Nachsorge bei mammakarzinom-patientinnen. Empfehlungen einer Konsensus-Tagung, Berlin 23.-24. 02. 1995
52. Impact of participation in randomized clinical trials on survival of women with early-stage breast cancer - An analysis of 7 985 patients